Three Key Takeaways From Ozempic and Zepbound Executives on Oprah Winfrey’s ‘Shame, Blame and the Weight Loss Revolution’ Special
Oprah Winfrey’s latest special, “Shame, Blame and the Weight Loss Revolution” aired Monday night on ABC. In the new hour-long program, the legendary host and producer discusses her journey using weight loss drugs and chats with experts about who are the best candidates to use them. Mounjaro and Ozempic, medications intended to treat type 2 diabetes, aren’t FDA approved to treat obesity; however, they have been prescribed off-label for weight loss management. Their key ingredients, semaglutide and tirzepatide, respectively, are FDA approved for weight loss under the brand names Wegovy and Zepbound. Amy Kane and Oprah Winfrey According to Negelle Morris, senior vice president, cardiometabolic sales, of Novo Nordisk, the Danish corporation behind Ozempic and Wegovy, the proliferation of these drugs signifies changing attitudes toward obesity. “It was actually over two decades ago that Novo Nordisk made a stand that obesity is a disease, and that the shame that society keeps on people who are dealing with excess weight and obesity needs to stop,” Morris told Winfrey. “As someone who struggles with excess weight and obesity, I have to remind myself constantly that this is not a personal failing.” Since hitting the market, the demand for all four drugs has drastically increased, leading to
from WWDRecent Stories https://ift.tt/S9AOzuD
Follow WWD on Twitter or become a fan on Facebook.
from WWDRecent Stories https://ift.tt/S9AOzuD
Comments
Post a Comment